ET Capital is focused on liberating the talent of the entrepreneurs we back.
ET Capital Limited
15a Water Lane
+44 (0)1223 236632
ADC Therapeutics Announces First Patients Dosed in Phase I/II Clinical Trial of ADCT-602 in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
Phico Therapeutics awarded Innovate UK funding for £1.4 million ($1.87M) antibacterial therapy project.